Ginny Mason, Executive Director of the Inflammatory Breast Cancer Research Foundation, shared a post on LinkedIn:
“When did making money become the most important thing in so many people’s lives that they would bet on clinical trial results? We all know research is ‘a gamble’ regarding outcomes but to open it to ‘prediction markets’…..”
You can also read: Kalshi is Betting on Trial Results and FDA Decisions Now, What’s Next?
